Mobile AL 非小细胞肺癌临床试验
13项针对 非小细胞肺癌的研究正在 Mobile及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
招募中2/3 期
- Southern Cancer Center, P.C., Daphne · 距离 10 英里
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
招募中3 期
- Southern Cancer Center Pc, Daphne · 距离 10 英里
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
招募中3 期
- Southern Cancer Center Pc, Daphne · 距离 10 英里
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
招募中3 期
- Southern Cancer Center, Daphne · 距离 10 英里
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
招募中2 期
- Southern Cancer Center, PC, Daphne · 距离 10 英里
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
招募中3 期
- Infirmary Cancer Care, Mobile
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
招募中3 期
- Local Institution - 0487, Mobile
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- Mobile Infirmary Medical Center, Mobile
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland, Saraland · 距离 9 英里
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne · 距离 10 英里
- 以及另外 1 项
MYLUNG Consortium Part 3: Observational Study
招募中观察性研究
- Southern Cancer Center, PC, Daphne · 距离 10 英里
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
招募中2 期
- Mobile Infirmary Medical Center, Mobile
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland, Saraland · 距离 9 英里
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne · 距离 10 英里
- 以及另外 1 项
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
招募中2/3 期
- Mobile Infirmary Medical Center, Mobile
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland, Saraland · 距离 9 英里
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne · 距离 10 英里
- 以及另外 1 项
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
招募中
- University of South Alabama, Mobile
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Mobile
其他城市的 非小细胞肺癌试验
- Houston, TX145 项研究
- New York City, NY120 项研究
- Arlington, VA104 项研究
- Nashville, TN97 项研究
- Boston, MA90 项研究
- Los Angeles, CA87 项研究
- St. Louis, MO73 项研究
- Chicago, IL61 项研究
- Baltimore, MD60 项研究
- San Antonio, TX59 项研究
- Columbus, OH56 项研究
- Washington, DC55 项研究
Mobile的其他研究
- 心力衰竭13 项研究
- 肺癌7 项研究
- 乳腺癌7 项研究
- 卵巢癌7 项研究
- 肥胖症7 项研究
- 癌症（所有类型）6 项研究
- 黑色素瘤6 项研究
- 小细胞肺癌6 项研究
- 心血管疾病6 项研究
- 心房颤动5 项研究
- 超重5 项研究
- 2型糖尿病5 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。